FD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state | Journal of controlled release | 2000 | 196 | 0 | |||
| Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer Nanoparticles | Pharmaceutical development and technology | 2000 | 79 | 0 | |||
| Freeze-drying of PLA-PEO nanoparticles : from basic principles to rational optimization | CRS proceedings | 1999 | 233 | 72 | |||
| Cellular uptake of nanoparticles made of poly(lactic acid), poly(ethylene oxide) diblock and triblock copolymers | CRS proceedings | 1999 | 59 | 40 | |||
| Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake | Pharmaceutical research | 1999 | 49 | 153 | |||
| Nanoparticles | Encyclopedia of controlled drug delivery | 1999 | 208 | 0 | |||
| PLA-PEG nanoparticles: preparation and cell interaction studies | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 47 | 53 | |||
| Biodegradable nanoparticles — From sustained release formulations to improved site specific drug delivery | Journal of controlled release | 1996 | 99 | 0 | |||
| An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes | Life sciences | 1995 | 155 | 1 |
